Literature DB >> 12425835

[Results of bronchoplasty by fiberoptic bronchoscopic balloon dilatation in the management of proximal benign tracheobronchial stenosis].

Qiang Li1, Chong Bai, Yuchao Dong, Lijun Zhao, Xiaopeng Yao, Hao Xu, Zhonglin Liu, Qin Wang.   

Abstract

OBJECTIVE: To assess the effect and safety of balloon dilatation through fiberoptic bronchoscopy in the management of benign tracheobronchial stenosis.
METHODS: Thirty-seven patients with proximal benign tracheobronchial stenosis were treated by balloon dilatation through flexible fiberoptic bronchoscopy. A fiberoptic bronchoscope was inserted, a balloon catheter was sent to the stenotic segment from the working channel and positioned in the stenotic bronchus. Under direct visualization, the balloon was inflated for 1 min to 3 min. Repeat inflation-deflation cycles were done if airway narrowing remained after the initial operation. Before the procedure and immediately after the last operation, airway diameters, dyspnea index and complications were evaluated in all of the patients and FEV(1) was tested in 26 of the 37 patients.
RESULTS: One to 6 operations (2.4 +/- 1.1, approximately x +/- s) were required to achieve satisfactory dilatation. After high-pressure balloon dilatation, the average airway diameter increased from (2.6 +/- 1.2) mm to (6.9 +/- 1.8) mm (P < 0.01). Dyspnea index decreased from 2.0 +/- 0.8 to 0.7 +/- 0.6 (P < 0.01). FEV(1) was increased from (1.3 +/- 0.6) L to (1.8 +/- 1.0) L (P < 0.01). No severe complications were found in these patients
CONCLUSION: Bronchoplasty by high-pressure balloon dilatation through flexible fiberoptic bronchoscopy is a simple but effective and safe method to treat proximal benign tracheobronchial stenosis.

Entities:  

Mesh:

Year:  2002        PMID: 12425835

Source DB:  PubMed          Journal:  Zhonghua Jie He He Hu Xi Za Zhi        ISSN: 1001-0939


  1 in total

1.  Appropriate treatment sessions of flexible bronchoscopic balloon dilation for patients with nonmalignant central airway stenosis.

Authors:  Weiquan Liang; Peicun Hu; Wenliang Guo; Zhuquan Su; Jingxian Li; Shiyue Li
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.